The evolution of renal function and the incidence of end-stage renal disease in patients aged ≥50 years

Nephrology Dialysis Transplantation

Volumn 27, Issue 6, 2012, Pages 2297-2303

  Van Pottelbergh, Gijs ^a   Bartholomeeusen, Stephaan ^a   Buntinx, Frank ^a,b   Degryse, Jan ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Chronic kidney disease; End stage renal disease; Glomerular filtration rate; Older patients; Primary health care

Indexed keywords

CHOLESTEROL; CREATININE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DATA BASE; DIABETIC PATIENT; DISEASE COURSE; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SURVIVAL RATE;

EID: 84861913428     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr659     Document Type: Article

References (25)

1. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008; 8: 117
2. Garg AX, Papaioannou A, Ferko N et al. Estimating the prevalence of renal insufficiency in seniors requiring long-term care. Kidney Int 2004; 65: 649-653
3. Khan S, Amedia CA Jr. Economic burden of chronic kidney disease. J Eval Clin Pract 2008; 14: 422-434
4. Black C, Sharma P, Scotland G et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess 2010; 14: 1-184
5. Tonelli M, Muntner P, Lloyd A et al. Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med 2011; 154: 12-21
6. Bartholomeeusen S, Kim CY, Mertens R et al. The denominator in general practice, a new approach from the Intego database. Fam Pract 2005; 22: 442-447
7. https://www.wiv-isp.be/ClinBiol/bckb33/activities/external-quality/ rapports/-down/klinische-chemie/2010/1-CHEMIE.pdf (9 November 2011, date last accessed)
8. Levey AS, Greene T, Kusek JW et al. A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol 2000; 11: 155A
9. Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 2006; 69: 375-382
10. Levey AS, Berg RL, Gassman JJ et al. Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int Suppl 1989; 27: S73-S80
11. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33: 278-285
12. Danziger RS, Tobin JD, Becker LC et al. The age-associated decline in glomerular filtration in healthy normotensive volunteers. Lack of relationship to cardiovascular performance. J Am Geriatr Soc 1990; 38: 1127-1132
13. Hallan SI, Dahl K, Oien CM et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 2006; 333: 1047
14. O'Hare AM, Choi AI, Bertenthal D et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 2007; 18: 2758-2765
15. Collins AJ, Foley RN, Gilbertson DT et al. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol 2009; 4 (Suppl 1): S5-S11
16. Hallan SI, Orth SR. The conundrum of chronic kidney disease classification and end-stage renal risk prediction in the elderly what is the right approach? Nephron Clin Pract 2010; 116: c307-c316
17. Kastarinen M, Juutilainen A, Kastarinen H et al. Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25,821 men and women in eastern Finland. J Intern Med 2010; 267: 612-620
18. Iseki K, Ikemiya Y, Fukiyama K. Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int 1997; 51: 850-854
19. Hsu CY, Iribarren C, McCulloch CE et al. Risk factors for endstage renal disease: 25-year follow-up. Arch Intern Med 2009; 169: 342-350
20. Simons PC, Algra A, Bots ML et al. Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease). Circulation 1999; 100: 951-957
21. Raptis AE, Viberti G. Pathogenesis of diabetic nephropathy. Exp Clin Endocrinol Diabetes 2001; 109 (Suppl 2): S424-S437
22. Jafar TH, Schmid CH, Stark PC et al. The rate of progression of renal disease may not be slower in women compared with men: a patientlevel meta-analysis. Nephrol Dial Transplant 2003; 18: 2047-2053
23. Kaushik M, Sontineni SP, Hunter C. Cardiovascular disease and androgens: a review. Int J Cardiol 2010; 142: 8-14
24. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
25. Bartholomeeusen S, Truyers C, Buntinx F. Ziekten in de huisartsenpraktijk in Vlaanderen (1994-2008). ACCO 2010